Orphan Drugs Research and Commercialization Conference
- Start Date:
- Wednesday, 8 May, 2013
- End Date:
- Friday, 10 May, 2013 3:00pm
- Cardiology, Emergency Medicine, Critical Care, Allergy
GTC is proud to announce its inaugural Orphan Drugs Research and Commercialization Conference at a crucial time in the rare disease space. Rather than merely reciting the challenges of orphan drug development, it is time all stakeholders in the community come together to find innovative solutions in order to better serve rare disease patients. This meeting connects industry, academia, regulators, and patient groups to dialogue about strategies to improve orphan drug research, pricing, reimbursement, access, and other key topics.
The Orphan Drugs Research and Commercialization Conference is one of four parallel tracks to the 2nd Novel Technologies in Drug Discovery Summit on May 8 - 10, 2013 in Boston, MA. Tentative Sessions Include: Pre-Conference Workshop: Developing an Effective Pricing and Reimbursement Strategy Novel Therapeutics in Rare Diseases Designing Effective Clinical Trials Case Studies in the Preclinical and Clinical Space Partnering in Rare Diseases Commercialization of Orphan Drugs Panel Discussion: Regulatory in Orphan Drug Development We look forward to seeing you at the Orphan Drugs Research and Commercialization Conference! Conference Date: May 08-10, 2013 Venue: Hyatt Regency, 1 Ave De Lafayette, Boston, Massachusetts Event Link: http://www.gtcbio.com/component/conference/?file=home&cn=Orphan+Drugs+Research+and+Commercialization&cid=114&utm_source=ConfWebsite&utm_medium=Posting&utm_campaign=OrphanPost
1 Ave De Lafayette,
Conference organized by GTCbio
We invite you to attend the 4th Immunogenicity & Immunotoxicity Conference, which will take place on January 25-26, 2016 in San Diego, CA.
- 635 W. Foothill Blvd. Monrovia, CA